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Abstract
Red blood cells (RBCs) are continuously exposed to oxidative stress (OS), 
mainly due to their primary function as oxygen carriers. Since RBC is a unique cell, 
without nucleus or other organelles, it presents a very special metabolism and a 
highly efficient antioxidant system to face OS conditions. Hemoglobin and RBC 
membrane are the major targets of oxidative modifications when RBC antioxidant 
capacity is overwhelmed. Fortunately, non-enzymatic agents, such as glutathione, 
and enzymatic agents, namely, several peroxidases, such as catalase, glutathione 
peroxidase and peroxiredoxin 2, are able to prevent OS damage. Although these per-
oxidases are mainly cytosolic enzymes, evidence exists about their association to the 
RBC membrane. So far, it appears that the relative importance of the three enzymes 
is related to hydrogen peroxide levels within the RBC. In this chapter, we will focus 
on the importance of these peroxidases in the RBC’s defense against OS mainly in 
the RBC cytosol and also the interplay between them and the RBC membrane. The 
potential role of their binding to the membrane will also be addressed.
Keywords: erythrocyte peroxidases, erythrocyte membrane, hemoglobin, 
oxidative stress, erythrocyte antioxidant system
1. Introduction
Erythrocytes are the most abundant cells in human blood, with unique morphol-
ogy and metabolic characteristics and are highly important for body homeostasis. 
Erythrocytes come from a hematopoietic process—erythropoiesis—by which 
hematopoietic stem cells from the bone marrow proliferate and differentiate into 
mature red blood cells (RBCs) [1–3]. Erythrocytes are enucleated cells with a 
cytoplasm without organelles and rich in hemoglobin (Hb), which represents about 
95% of total erythrocyte’s cytoplasmic proteins [4, 5].
Membrane structure and composition are responsible for the biconcave disc 
shape and for the high deformability of the cell. These features are essential for 
oxygen transport, since RBCs have to undergo repeated shape changes without 
fragmentation, to assure their passage and oxygen perfusion through all vascular 
networks, namely, through capillary blood vessels with smaller lumen diameter 
than that of RBCs [6, 7]. Modifications in RBC membrane protein structure, by 
decreasing membrane flexibility and stability, may lead to premature removal of 
the cell reducing RBC’s life span [1, 8].
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The erythrocyte membrane is a complex structure composed by a lipid bilayer 
and a protein-based cytoskeleton tethered together by transmembrane proteins, such 
as protein band 3 and glycophorins. When under oxidative stress (OS) conditions, 
Hb is oxidized, it binds to the cytoplasmic domain of membrane protein band 3, 
triggering the formation of aggregates and the covalent linkage of natural anti-band 
3 antibodies that may lead to premature RBC removal by splenic macrophages [1, 9].
Hb, the main cytoplasmic protein in RBC, is extremely important for eryth-
rocyte’s primary function, as a gas exchanger and for performing oxygen (O2) 
distribution to body tissues. Erythrocytes carry O2 from the lungs to the tissues and 
mediate carbon dioxide removal from the tissues to the lungs. In the lungs, O2 binds 
to the heme group in Hb; in the tissues, O2 is unloaded from Hb that undergoes a 
spatial rearrangement of the globin chains, allowing the entry of 2,3-diphospho-
glycerate (2,3-DPG) which diminishes O2 affinity [1, 2]. Oxyhemoglobin suffers 
autoxidation daily (2–3%), with oxidation of heme ferrous iron into ferric iron 
[10], leading to the formation of methemoglobin (metHb), which is not capable of 
O2 transport, and the release of superoxide anion that is converted to H2O2, with 
a lower oxidant capacity [11]. The erythrocytes are capable of reducing metHb to 
functional Hb through methemoglobin reductases and of detoxifying the cell from 
H2O2 through the glutathione metabolism [2].
To prevent or reverse the harmful effects of OS, leading to oxidative changes 
in the erythrocyte constituents, RBCs are equipped with a powerful antioxidant 
system that is able to protect not only themselves, but also other cells and tissues 
while circulating throughout the vascular network. The protective antioxidant 
mechanisms of RBCs include enzymatic and non-enzymatic antioxidant systems 
that work together to detoxify the cell from reactive oxygen species (ROS) produced 
within or outside the cell.
In this chapter, we will focus on the importance of the RBC enzymatic antioxi-
dant systems, namely on the peroxidases catalase (CAT), glutathione peroxidase 
(GPx) and peroxiredoxin 2 (Prx2). These peroxidases have a major role in the RBC’s 
defense against OS, although the interplay between them is still a topic of discus-
sion, as well as the potential role of their binding to the membrane, which may 
provide a protective mechanism for the cell.
2. Erythrocyte metabolism
Erythrocytes have a limited metabolic capacity since they lack a nucleus and 
organelles, like mitochondria, for oxidative metabolism [1, 11]. Therefore, energy is 
generated by the anaerobic glycolytic Embden-Meyerhof pathway, through which 
the breakdown of glucose to lactate generates two ATP molecules (Figure 1). This 
energy is essential for the maintenance of RBC’s shape, membrane deformability 
and regulation of sodium-potassium pump [1, 2]. This pathway also provides 
NADH, which is important as a cofactor of methemoglobin reductase to regenerate 
oxidized Hb to its reduced functional state. The Luebering-Rapoport shunt, a side 
arm of Embden-Meyerhof pathway, produces 2,3-DPG (Figure 1), essential for 
the regulation of O2 affinity [1, 2]. Around 80–90% of glucose that enters the cell 
follows the Embden-Meyerhof pathway, while about 10% is metabolized through 
the pentose phosphate pathway [12] to ribose-5-phosphate concomitantly generat-
ing NADPH (Figure 1). NADPH is essential for glutathione (GSH) metabolism 
that assures the detoxification of RBCs from ROS, being, therefore, an important 
erythrocyte antioxidant defense mechanism [11].
GSH is a tripeptide constituted by the three amino acids L-glutamate, L-cysteine 
and L-glycine [13, 14], existing in the cell in two different forms, the reduced form 
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(GSH) and the oxidized form (GSSG). The reduced form is the predominant one 
and GSSG is maintained at low levels, less than 1% mainly by the action of NADPH-
dependent glutathione reductase [13], which converts GSSG into the reduced GSH 
(Figure 1). Despite the limited biosynthesis capability of the RBC, some endogenous 
GSH is still synthetized in the cytosol through two ATP-dependent reactions catalyzed 
by two different enzymes, glutamate cysteine ligase and glutathione synthase [13].
As an antioxidant defense, GSH has several roles: it can directly scavenge hydroxyl 
radicals and peroxynitrites [14, 15]; it is involved in lipid peroxide detoxification 
[16]; it can reduce H2O2 in the presence of GPx by the reduction of its thiol group and 
keeps thiol groups from Hb, enzymes and membrane proteins in the reduced form 
[13], which is very important for the preservation of their functions, once oxida-
tion of these groups can lead to functional and structural cellular modifications. 
Therefore, the GSH/GSSG ratio is an important indicator of the cell redox state [15].
In OS conditions, the capacity of RBCs to reduce GSSG to GSH decreases, lead-
ing to GSSG accumulation and, consequently, to GSH depletion [14]. Diminished 
GSH concentrations have been described in physiological events, as aging, and in 
pathologic conditions associated with OS, such as Alzheimer’s disease, Parkinson’s 
disease [15], sickle cell anemia and asthma [17, 18].
Ascorbic acid (vitamin C) and α-tocopherol (vitamin E) obtained mostly from 
diet are also important non-enzymatic erythrocyte antioxidants [19]. α-Tocopherol 
has a protective effect on RBC membranes against lipid peroxidation [11, 19]. 
Ascorbic acid can reduce O2
− levels and it is an important regenerator of α-tocopherol. 
Uric acid can also act as an antioxidant and is able to directly scavenge OH− [12].
3. Oxidative stress in erythrocytes
During their life span, the erythrocytes are continuously exposed to high O2 ten-
sion, due to their primary function as gas carriers, and are unable to synthesize new or 
repair damaged proteins, due to the lack of nucleus and other organelles. Therefore, 
RBCs are more vulnerable to ROS action than other cells of the human body [12].
Figure 1. 
Erythrocyte metabolic pathways synopsis. 2,3 DPG, 2,3-diphosphoglycerate; ADP, adenosine diphosphate; ATP, 
adenosine triphosphate; G-6-P, glucose 6-phosphate; GPx, glutathione peroxidase; GR, glutathione reductase; 
GSSG, oxidized glutathione; GSH, glutathione; Hb, hemoglobin; metHb, methemoglobin; NAD, NADH, 
nicotinamide adenine dinucleotide; NADP, NADPH, nicotinamide adenine dinucleotide phosphate.
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ROS are chemically reactive species containing oxygen with one or more 
unpaired electrons that are formed by the reduction of an O2 molecule (Figure 2) 
[12, 20, 21]. The transfer of one electron to an O2 molecule produces superoxide 
anion (O2
−), the precursor of other ROS [22]. Spontaneous O2
− dismutation or 
catalysis by superoxide dismutase (SOD) action produces hydrogen peroxide (H2O2) 
[22]. This molecule is not a free radical and is more stable than O2
−, but it can easily 
cross cell membranes and cause damage in other cells and tissues [12]. The RBC 
needs to be detoxified from H2O2, as its accumulation leads to the production of 
other more potent ROS. This molecule can be decomposed into water and O2 by 
CAT, GPx or Prx2. In case of failure of these antioxidant enzymes, H2O2 can also 
be reduced to hydroxyl radical (OH−), the most harmful free radical for biological 
systems, due to its high reactivity. With a short half-life, OH− does not travel far, but 
has a much higher oxidant potential than all the other ROS [12, 20].
OS arises when an imbalance between free-radical formation and antioxidant 
defenses occurs, that is, when ROS concentration overwhelms the antioxidant 
capacity within the RBC [19]. The endogenous source of ROS in erythrocytes is the 
autoxidation of Hb [11, 12]; occasionally oxyhemoglobin loses one electron (2–3% 
per day) leading to the production of O2
− and oxidized Hb (metHb) (Figure 2) 
which is not able to bind and carry O2. Erythrocytes can also develop OS due 
to exogenous ROS that are able to diffuse and cross the RBC membrane. The 
enhanced production and release of ROS by activated inflammatory cells, macro-
phages, neutrophils and endothelial cells [23], are the main source of exogenous 
ROS. The continuous exposure of RBCs to ROS can cause cell damage, includ-
ing lipid and protein oxidation, causing damages in enzymes and ion transport 
proteins [19, 24].
Considering the major role of Hb, its oxidation may trigger important struc-
tural and functional changes in RBCs [11, 12]. Thus, as oxidation of Hb occurs, 
even under normal physiological conditions, the antioxidant defenses have a 
crucial role in the regeneration of functional Hb and maintenance of low metHb 
Figure 2. 
Oxidative stress in erythrocytes. (1) Production of reactive oxygen species resulting from hemoglobin 
autoxidation. (2) Linkage of denatured Hb to erythrocyte membrane band 3 protein. (3) Peroxidation of 
erythrocyte membrane lipids. CAT, catalase; e−, electron; GPx, glutathione peroxidase; H+, hydrogen; H2O, 
water; H2O2, hydrogen peroxide; Hb, hemoglobin; HO
−, hydroxyl radical; LPO, lipid peroxidation; metHb, 
methemoglobin; O2, oxygen; O2
−, superoxide anion; Prx2, peroxiredoxin 2; SOD, superoxide dismutase.
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levels [11]. When oxidized, the primary structure of Hb is altered by the estab-
lishment of disulfide cross-links between globin chains that make the molecule 
unstable, leading to the formation of Heinz bodies and, eventually, to a premature 
RBC removal [11]. Indeed, oxidized Hb binds to the cytoplasmic domain of band 
3 protein in the RBC membrane (Figure 2), triggering band 3 clustering, mark-
ing the erythrocyte for removal by splenic macrophages [23, 25]. Clustering of 
band 3 as a result of enhanced metHb formation and linkage to the membrane has 
been reported in several erythrocyte disorders such as, hereditary spherocytosis 
[26], beta-thalassemia [27], sickle cell anemia [28] and glucose-6-phosphate 
dehydrogenase deficiency [29]. An increase in metHb levels and in its linkage to 
the RBC membrane, accompanied by ROS formation, was also found in stored 
RBCs for blood transfusion [30] and in exogenous H2O2-induced OS upon healthy 
erythrocytes [31, 32]. Hb oxidation also occurs as a natural process, resulting from 
RBC aging [33], that is associated with metabolic degradation due to reduction in 
enzyme activity.
RBC membrane is an important target for both endogenous and exogenous 
ROS that may induce oxidative changes in membrane proteins and lipids. Changes 
in RBC membrane proteins have been reported in some diseases in which OS is 
involved, such as chronic kidney disease [34, 35] or chronic obstructive pulmonary 
disease [36]. ROS can affect erythrocyte proteins through oxidation of the protein 
backbone, cross-linking or amino acid oxidation [19, 24]. The polyunsaturated 
fatty acids (PUFAs) of the RBC cell membranes are highly vulnerable to oxidation 
(about half of the RBC membrane fatty acids are unsaturated [12]). ROS are able 
to break the double bonds of PUFA, producing malondialdehyde (MDA) [24], the 
main end-product of membrane lipid peroxidation (LPO). MDA is a highly reactive 
molecule that can further react with lipids and proteins of the membrane. These 
changes in membrane proteins and lipids contribute to functional and structural 
alterations that decrease erythrocyte membrane stability and deformability and 
trigger premature RBC removal [12, 24]. LPO has also been described following 
metHb binding to the membrane, suggesting that this linkage favors LPO [37]. 
Increased LPO and MDA levels have been reported in different conditions associ-
ated to OS, including physiological events, such as aging [38], and pathological 
conditions like schizophrenia [39], Alzheimer’s disease [40], inflammatory 
associated diseases [41], atherosclerosis [42] and chronic kidney disease [43]. 
Considering the reduced biosynthetic capacity of erythrocytes, they accumulate 
oxidative changes along their life span and, therefore, the OS-induced changes in 
RBCs could be used as useful biomarkers in several pathological and physiological 
conditions.
4. Erythrocyte peroxidases
To cope with oxidative injuries, the erythrocytes have several enzymes that 
neutralize ROS or transform them into less reactive species. SOD provides the 
first line of protection against free radicals. It is a cytosolic copper-zinc containing 
enzyme that converts O2
− into the less reactive H2O2 (Eq. (1)), through the alternate 
reduction and re-oxidation of Cu2+ [44].
  2  O 2 
.− + 2  H + →  H 2  O 2 +  O 2  (1)
Afterward, H2O2 can be decomposed into O2 and water by three distinct erythro-
cyte peroxidases: CAT, GPx and Prx2 [45–47].
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4.1 Catalase
Catalase (H2O2:H2O2 oxidoreductase, EC 1.11.1.6) is an intracellular enzyme 
found at high concentrations in erythrocytes and liver peroxisomes in mammals 
[48–51]. CAT is a very important enzyme, as it is able to protect cells and tissues 
from the toxic effects of H2O2 [19, 51]. As referred, the decomposition of H2O2 is 
particularly important in erythrocytes, to prevent oxidation of Hb and of other 
RBC constituents. CAT is one of the most efficient enzymes, since it exhibits one of 
the fastest turnover rates with a capacity to convert millions of H2O2 molecules per 
second (kcat = 4 × 107 s−1) [45, 48].
More than 300 catalase sequences are available, divided among several groups 
[45, 50, 52]. Human erythrocyte catalase, a tetrameric protein of 244 kDa [53], 
belongs to the monofunctional heme-containing catalases. Each monomer is 
formed by a single polypeptide chain that has a molecular weight of approximately 
60 kDa [54]. Each subunit also has one heme group at the catalytic center, with iron 
(III) linked to protoporphyrin IX [53]. Some studies [55–57] showed that each cata-
lase tetramer has four tightly bound NADPH molecules that appear to be important 
only to protect the enzyme against inactivation by its own substrate (H2O2), and are 
not essential for its catalytic activity. It is thought that NADPH prevents the forma-
tion of the inactive form of catalase (Compound II) and that it increases the rate of 
removal of this inactive form [45, 53, 55, 56].
The overall reaction catalyzed by CAT involves the degradation of two molecules 
of H2O2 to two molecules of water and one of O2 (Eq. (2)).
  2  H 2  O 2 → 2  H 2 O +  O 2  (2)
The H2O2 decomposition is believed to occur in two steps (Figure 3, steps 1 
and 2) [45, 50, 52]. The first involves the interaction between one molecule of H2O2 
and CAT which leads to the production of Compound I, in which the heme group is 
oxidized to oxyferryl species [45, 50, 52]. Compound I is an enzymatic active form 
Figure 3. 
Hydrogen peroxide removal by catalase. (1) Interaction between H2O2 and catalase leading to the production 
of Compound I. (2) Interaction of a second H2O2 molecule with Compound I producing one molecule of H2O, 
O2 and the enzyme at the resting state. (3) Catalase peroxidatic activity. H2O, water; H2O2, hydrogen peroxide; 
O2, oxygen.
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of catalase but spectroscopically different [58]. At the second step, a second H2O2 
molecule acts, as a reducing agent, on Compound I, producing one molecule of 
water, one of O2 and the enzyme in the resting state [45, 50, 52].
In addition to their catalytic activity, catalases can also function peroxidatively 
(Figure 3, step 3) to eliminate H2O2 [45, 49]. In this case, the enzyme uses peroxida-
tion to eliminate H2O2 molecules by oxidizing substances like alcohols. The peroxi-
datic activity of CAT is, usually, minor, weak and restricted to smaller substrates, as 
compared to other peroxidases [45].
When compared with the other H2O2 scavenger enzymes, CAT seems to be the 
key enzyme to remove high intracellular concentrations of H2O2 [32, 53, 59, 60]. 
Moreover, CAT is highly specific for its substrate, H2O2, and it is not able to elimi-
nate organic peroxides, unlike other peroxidases [59].
Catalase has also been studied in a number of different diseases in which OS is 
implicated, such as, diabetes mellitus where patients presented lower CAT values 
[61]; in some type of cancers, CAT activity was lower in patients, especially in 
lymphomas, when compared with CAT activity in the normal population [62] and, 
in bipolar disorder, subjects with bipolar depression presented a significant increase 
in CAT levels [63].
4.2 Glutathione peroxidase
GPx (GSH2:H2O2 oxidoreductase, EC 1.11.1.9) is an intracellular antioxidant 
enzyme that contributes to prevent H2O2 accumulation in cells. In mammals, eight 
GPxs have been identified [47] at different locations and cellular compartments, 
differing at their catalytic center. GPx-1 is one of the most abundant type of GPx 
and the only type present in RBC’s cytosol [60]. GPx-1 is a tetramer of four identi-
cal subunits of 21 kDa [64], each with one selenocysteine (Sec) [65]. The catalytic 
tetrad formed by Sec, glutamine, tryptophan and asparagine is essential for GPx 
activity, since these residues are crucial for enzyme-substrate interaction and 
stabilization of the GSH-GPx interaction [47, 65, 66].
GPx-1 catalyzes the reduction of H2O2 [47, 66], lipid hydroperoxides and other 
low molecular hydroperoxides [64] into water, or into the corresponding alcohols, 
using GSH as a reducing agent; thus, GPx-1 prevents both lipid peroxidation [65, 
67] and H2O2 accumulation.
The overall catalytic reaction of GPx-1 is given by Eq. (3).
  ROOH + 2GSH → ROH +  H 2 O + GSSG  (3)
The catalytic cycle of GPx includes a peroxidatic part that is followed by a 
reductive step (Figure 4) [47]. In the peroxidatic part, one molecule of H2O2 reacts 
with the selenol group from Sec in GPx, producing a selenenic acid at the active site 
[47, 66]. In the reductive part, one GSH molecule forms a selenadisulfide bond with 
the selenic acid forming the glutathiolated selenol intermediate [47]. As a second 
GSH molecule reduces the glutathiolated selenol bond, GSSG is released and GPx is 
regenerated. The restoration of GSH involves the action of the NADPH-dependent 
enzyme, glutathione reductase. The recycling of NADPH associates the GSH system 
to the pentose-phosphate pathway [66].
CAT was considered as the only enzyme involved in erythrocyte antioxidant 
defense by performing H2O2 removal [68]. Nowadays, it is known that GPx also has 
a major role in RBC antioxidant protection, being essential for the detoxification 
of low H2O2 concentrations and hydroperoxides [59, 69, 70], with a constant rate 
superior to 107 M−1 s−1 [47, 71].
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4.3 Peroxiredoxin 2
Peroxiredoxins (Prxs; SH:H2O2 oxidoreductases, EC 1.11.1.15) are a fam-
ily of homodimeric peroxidases with an antioxidant role in living organisms. 
Six different mammalian Prx isoforms are known (Prx 1–6). Prx 1 and Prx 6 can 
be found in erythrocytes, although in much lower amounts than Prx2, which 
is the third most abundant protein in the RBC cytosol (after Hb and carbonic 
 anhydrase) [5].
For a long time, CAT and GPx were considered the major erythrocyte players 
for H2O2 detoxification [68]. However, several studies [72–75] have shown the 
significant role of Prx2 as an efficient H2O2 scavenger in the erythrocyte antioxi-
dant system. Studies using Prx2 knock-out mice showed that these animal models 
developed hemolytic anemia and their erythrocytes displayed a significantly 
shorter life span, when compared to wild-type mice [72]. In contrast, CAT and GPx 
knock-out mice showed a normal hematologic profile and normal development [72, 
76]. Another important study reported that Prx2 reacts with H2O2 at a constant rate 
(1.3 × 107 M−1 s−1) comparable with that of CAT and GPx [75].
Under its physiological functional state, Prx2 appears as a monomer (active 
form) of about 20–30 kDa and when interacting with H2O2, Prx2 is oxidized and a 
disulfide-linked dimmer is formed (inactive form) [73, 77]. This oxidized form is 
reversed by thioredoxin (Trx)/Trx reductase/NADPH system, although, in RBCs, 
it is a very slow regeneration due to the low concentrations of Trx reductase [73]. 
Besides H2O2, Prx2 can also remove peroxynitrites [5] and hydroperoxides in the 
RBC membrane [73, 75].
Since Prx2 is a thiol-dependent peroxidase, it uses redox-active cysteines to 
reduce peroxides. According to the number and location of the catalytic cysteines, 
Prxs are divided into three classes: the typical 2-Cys, the atypical 2-Cys and the 
1-Cys [46]. Prx2 is a typical 2-Cys peroxiredoxin, with two redox-active cysteines: 
the peroxidatic cysteine near residue 50 in one subunit and the resolving cysteine 
near residue 170 in the other subunit [46]. The overall peroxidase reaction is given 
by Eq. (4).
  ROOH + 2  e − → ROH +  H 2 O  (4)
Figure 4. 
Catalytic cycle of glutathione peroxidase 1. (1) Peroxidatic part of GPx-1 catalytic cycle. (2) and (3) Reductive 
part of GPx-1 catalytic cycle (4) Regeneration of GSH by NADPH-dependent GR. (5) NADP+/NADPH 
recycling by G6PD. 6PG, 6-phosphogluconolactone; G6P, glucose-6-phosphate; G6PD, glucose-6-phosphate 
dehydrogenase; GPx-SeH, glutathione peroxidase selenol; GPx-SeOH, glutathione peroxidase selenic acid; 
GPx-Se-SG, glutathiolated selenol intermediate; GR, glutathione reductase; GSH, glutathione; GSSG, oxidized 
glutathione; H2O, water; H2O2, hydrogen peroxide; NADPH/NADP
+, nicotinamide adenine dinucleotide 
phosphate.
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The catalytic cycle of Prx2 is composed by two steps (Figure 5). The first step 
is the oxidation of peroxidatic cysteine to peroxidatic cysteine-sulfenic acid by 
interaction with H2O2. In the second step, the resolving cysteine of one Prx subunit 
attacks the peroxidatic cysteine-sulfenic acid of the other subunit generating an 
inter-subunit disulfide bond [46, 75]. This dimeric form of Prx2 is non-functional, 
but the disulfide bridge between the subunits can be broken by Trx, regenerating 
Prx2, and completing the catalytic cycle [73]. In turn, Trx can be reduced by the 
NADPH-dependent Trx reductase. Reduction of the disulfide bond by Trx is the 
rate-limiting step in the Prx2 catalytic cycle [73].
In the presence of high peroxide levels, 2-Cys Prxs can become over-oxidized to 
their sulfinic acid form. In RBCs, this hyperoxidation of Prx2 does not occur, as it is 
counteracted by sulfiredoxin [60, 73].
As part of the erythrocyte antioxidant system, Prx2 is responsible for the 
removal of low H2O2 concentrations, since the Trx system has a limited capacity 
for Prx2 regeneration into its reduced active form [32, 59, 60, 73]. Recently, it was 
found that Prx2 can have a dual function according to H2O2 levels, as an antioxidant 
enzyme or as a chaperone, due to changes in its structure [59, 73, 78]. In RBCs, 
Prx2 can bind to Hb under OS conditions to stabilize its structure and prevent Hb 
aggregation [79]. A recent work by our group [80] showed that under steady-state 
conditions, Prx2 acts as a typical peroxidase, protecting the erythrocytes from 
low endogenous levels of ROS. However, when RBCs are saturated with carbon 
monoxide, Prx2 was observed only in the active form in the cytosol and none in the 
oxidized form, suggesting that Prx2 is acting specifically to protect Hb, shifting its 
function from peroxidase to chaperone. Prx2, initially called calpromotin, is also 
required to regulate the calcium-dependent potassium channel in the erythrocyte 
membrane [81].
The use of Prx2 as a potential therapeutic drug target has gained growing inter-
est; so far, it has already been reported as a possible target for malaria treatment 
[82]. Changes in human Prx2 expression or oxidation state have been associated 
with several diseases: alterations in Prx2 expression have been reported in different 
types of cancer [83, 84]; oxidatively modified Prx2 has been found in Alzheimer’s 
disease patients [85]; hyperoxidized forms of Prx2 were also found in asthmatic 
patients [86] and linkage of cytosolic Prx2 to the RBC membrane was found in 
Figure 5. 
Peroxiredoxin 2 catalytic cycle. (1) Oxidation of SPH to SPOH by interaction with H2O2. (2) Attack of SRH 
of one subunit to SPOH of the other subunit and formation of the intersubunit disulfide bond. (3) Reduction 
of the disulfide bond by Trx. (4) Regeneration of reduced Trx by NADPH-dependent Trx reductase. 2-Cys 
Prx, 2-cys peroxiredoxin 2; H2O, water; H2O2, hydrogen peroxide; NADPH/NADP
+, nicotinamide adenine 
dinucleotide phosphate; SPH, peroxidatic cysteine; SPOH, peroxidatic cysteine sulfenic acid; SRH, resolving 
cysteine; Trx, thioredoxin; TrxR, thioredoxin reductase.
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hereditary spherocytosis patients [26]. Thus, there has been an increasing interest 
in Prx2 as a biomarker for different conditions where OS plays a crucial role. For 
example, a novel HPLC method to monitor the levels of reduced Prx2 form was 
developed [87], which could prove useful for future clinical practice.
5.  Interplay between erythrocyte peroxidases and the erythrocyte 
membrane
The individual contribution of CAT, GPx and Prx2 to erythrocyte protection 
against H2O2 damage has been a controversial issue for many years. It is clear that 
all three enzymes are involved in the prevention of H2O2 accumulation in the RBC 
through H2O2 conversion into water and O2 (Figure 6); however, the relative impor-
tance of the three enzymes is still a topic of discussion.
CAT was considered the main erythrocyte defense against OS, for many years 
[68, 88], but several studies [59, 69, 89] showed that GPx has also an important role 
in H2O2 decomposition. In fact, a study by Johnson et al. [59] showed that CAT and 
GPx-deficient RBCs were more sensitive to H2O2-induced OS than cells with only 
CAT deficiency, suggesting that GPx has an important role in erythrocyte defense. 
The same authors also showed [59, 70] that the action of both CAT and GPx was 
insufficient to explain the erythrocyte oxidative catabolism, and proposed [70] a 
model including Prx2 that, in accordance with their experimental data, could better 
explain the erythrocyte antioxidant defense system. Furthermore, the development 
of hemolytic anemia in Prx2 knock-out mice [72–74] and the high turnover rate 
of Prx2 with H2O2 [5, 75] strengthened the importance of the role of Prx2 in RBC 
antioxidant protection.
Figure 6. 
Interplay between erythrocyte’s peroxidases. (1) Methemoglobin formation and release of O2
−. (2) Formation 
of band 3 protein aggregates triggered by methemoglobin linkage to the integral membrane protein band 3. 
(3) O2
− removal by SOD with H2O2 formation. (4) H2O2 removal by CAT. (5) H2O2 removal by GPx. (6) 
H2O2 removal by Prx2. (7) Linkage of CAT, GPx and Prx2 to the RBC membrane imposed by oxidative 
stress. CAT, catalase; GPx, glutathione peroxidase; GR, glutathione reductase; GSH, glutathione; GSSG, 
oxidized glutathione; H2O, water; H2O2, hydrogen peroxide; Hb, hemoglobin; metHb, methemoglobin; Hb-O2, 
oxyhemoglobin; NADPH/NADP+, nicotinamide adenine dinucleotide phosphate; O2, oxygen; O2
−, superoxide 
anion; Prx2, peroxiredoxin 2; SOD, superoxide dismutase; Trx, thioredoxin; TrxR, thioredoxin reductase.
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The relative importance of the three enzymes appears to be related to the H2O2 
levels in the RBC [59]. CAT is able to scavenge exogenous and high endogenous 
peroxide levels [59, 60, 70], while GPx and Prx2 appear to scavenge endogenous 
and low peroxide levels [59, 70, 73]. Thus, the elimination of the basal flux and 
low H2O2 levels is performed by GPx and Prx2, since CAT does not work efficiently 
at low H2O2 levels [60]. Whenever RBCs are exposed to higher H2O2 levels, CAT 
becomes essential for its rapid removal since this enzyme has a high turnover rate, 
unlike GPx and Prx2 that become less efficient (or even inactive), due to their slow 
GSH reductase and Trx recycling systems, respectively [59, 60, 73].
The enzymes GPx and Prx2 seem to have other functions in RBC antioxidant 
defense, beyond H2O2 scavenging. In fact, GPx and Prx2 are also able to detoxify 
organic peroxides [5, 59, 75], while CAT does not show this function [59]. As shown 
by Johnson et al. [59, 90], GPx-deficient RBCs are more susceptible to oxidation 
by organic peroxides than wild type cells [90]; and when CAT deficiency was 
added to GPx deficiency, no increased sensitivity to oxidation by organic peroxides 
occurred in these cells [59]. Thus, when erythrocytes are exposed to high H2O2 
levels, organic peroxides will accumulate, since GPx and Prx2 become less efficient 
and CAT is not able to detoxify these organic peroxides [60].
Recently, it was reported that Prx2 can have multiple functions, as a peroxidase 
or as a chaperone, through the formation of high-molecular-weight complexes [78, 
91]. It was shown that Prx2 acts as a chaperone in RBCs, by interacting directly 
with Hb to maintain its stability [79]. A study by our group [80] showed that when 
erythrocytes were saturated with CO, the enzyme Prx2 was present in the cytosol 
only in the monomeric form, suggesting that Prx2 was not acting as a peroxidase 
but, instead, exclusively as a chaperone for Hb’s protection. Several authors have 
suggested [59, 92] that Prx2 can also have an important role in erythropoiesis. 
Johnson et al. [59] believe that the role of Prx2 as Hb chaperone is especially impor-
tant in the different stages of erythropoiesis. According to Matte et al., Prx2 appears 
to be a regulator of iron homeostasis during erythropoiesis [92].
CAT, GPx and Prx2 are essentially cytosolic enzymes; however, the association of 
these enzymes to the erythrocyte membrane has been reported in different in vivo 
and in vitro studies [26, 31, 32, 93–97]. Erythrocytes from patients with hereditary 
spherocytosis showed CAT [95] and Prx2 bound to their membranes [26]. The asso-
ciation of CAT to the membrane appears to be a consequence of the metabolic stress 
triggered by the destabilization of membrane structure, due to an altered RBC mem-
brane composition; the linkage of Prx2 might be involved in the protection of the 
RBC membrane against LPO [26, 31]. This linkage of Prx2 to the membrane appears 
to be through the N-terminal cytoplasmic domain of band 3, which is also the site of 
linkage of other cytoplasmic proteins, including metHb [98]. In recent in vitro assays 
performed by our group [32], we showed that H2O2-induced oxidative stress triggered 
the binding of Prx2 and GPx to RBC membrane. A recent study by Bayer et al. [96] 
about the interaction of Prx2 with the RBC membrane reported that the linkage of 
Prx2 to the membrane is independent of its redox state and that Prx2 competes with 
Hb for the same binding site in the RBC membrane. Thus, they demonstrated that 
Prx2 prevents metHb aggregation, and, probably acts as a chaperone for the dena-
tured Hb [96]. Contrary to what was previously observed [26, 31, 32], Bayer et al. 
[96] found a decrease in Prx2 membrane binding, with increasing concentrations of 
H2O2. A decrease in Prx2 linkage to the RBC membrane with OS conditions was also 
observed in beta-thalassemic mice RBCs, probably due to the increase in metHb that 
binds to the membrane, reducing the access of Prx2 to the same site [99].
The linkage of GPx to the RBC membrane was first described by van Gestel 
et al., using proteome analysis [94]. Later on, Rocha et al. showed the linkage of 
GPx to the RBC membrane in response to in vitro H2O2-induced OS [32].
Erythrocyte
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Studies of stored RBCs in blood bank conditions also reported the recruitment 
of Prx2, CAT and GPx to the RBC membrane due to OS modifications resulting 
from the metabolic stress of long-term erythrocyte storage [93, 97].
Data in literature suggest that the linkage of these RBC cytosolic enzymes to 
the membrane is triggered by metabolic stress, possibly, to protect the erythrocyte 
membrane and counteract the effects of OS.
6. Conclusions
Erythrocytes, as oxygen carrier cells, are highly exposed to oxidative injury; to 
face this challenge, RBCs are well equipped with an efficient antioxidant system, 
important to maintain erythrocyte homeostasis during its life span. The antioxidant 
system includes non-enzymatic and enzymatic agents such as peroxidases, namely 
Prx2, GPx and CAT. The role and interplay between these enzymes that prevent 
H2O2 accumulation in the erythrocyte has been a topic of discussion over the years. 
So far, it appears that their role depends on the H2O2 levels within RBC: CAT is 
crucial for scavenging high exogenous and endogenous peroxide levels, GPx and 
Prx2 are important for scavenging low endogenous and low peroxide levels. GPx 
and Prx2 are also able to detoxify the cell from organic peroxides, unlike CAT that 
does not show this function. Therefore, GPx and Prx2 can have a direct role on RBC 
membrane antioxidant defense.
Several authors have already reported the linkage of CAT, GPx and Prx2 to 
the erythrocyte membrane in case of metabolic stress and/or OS. In fact, the 
recruitment of the three peroxidases to the RBC membrane has been described in 
OS-associated conditions, by in vitro assays and by studies with stored RBCs under 
blood bank conditions.
Studies about Prx2 reveal a dual function in RBC defense, as a peroxidase and as 
an Hb chaperone preventing metHb aggregation. Some authors have also proposed 
that Prx2 may have a major role in erythropoiesis.
Erythrocytes are the ultimate antioxidant defense against the harmful effects 
of OS in humans; so, the knowledge about the RBC antioxidant system has evolved 
over time, and should continue to grow, focusing on the importance of CAT, GPx 
and Prx2 working together in ROS detoxification and also their potential role in the 
erythrocyte membrane.
Acknowledgements
Financial support from FCT/MCTES through national funds  UID/
MULTI/04378/2019 and Norte Portugal Regional Coordination and Development 
Commission (CCDR-N)/NORTE2020/Portugal 2020 (Norte-01-0145-
FEDER-000024) and a PhD grant (SRRH/BD/139622/2018) attributed to D. Melo.
Conflict of interest
The authors report no conflict of interest.
13
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
Interplay between Erythrocyte Peroxidases and Membrane
DOI: http://dx.doi.org/10.5772/intechopen.83590
Author details
Daniela Melo1, Susana Rocha1, Susana Coimbra2,3 and Alice Santos Silva1*
1 UCIBIO, REQUIMTE, Laboratory of Biochemistry, Department of Biological 
Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal
2 UCIBIO, REQUIMTE, Porto, Portugal
3 CESPU, Institute of research and Advanced Training in Health Sciences and 
Technologies (IINFACTS), Gandra-Paredes, Portugal
*Address all correspondence to: assilva@ff.up.pt
14
Erythrocyte
References
[1] Turgeon ML. Clinical Hematology: 
Theory and Procedures. 5th ed. USA: 
Lippincott Williams & Wilkins; 2010
[2] Hoffbrand AV, Moss PAH, Pettit 
IE. Essential Haematology. 5th ed. USA: 
Blackwell Publishing Ltd; 2006
[3] Tsiftsoglou AS, Vizirianakis IS, 
Strouboulis J. Erythropoiesis: Model 
systems, molecular regulators, and 
developmental programs. IUBMB Life. 
2009;61(8):800-830. DOI: 10.1002/
iub.226
[4] Hattangadi SM et al. From stem cell 
to red cell: Regulation of erythropoiesis 
at multiple levels by multiple proteins, 
RNAs, and chromatin modifications. 
Blood. 2011;118(24):6258-6268. DOI: 
10.1182/blood-2011-07-356006
[5] Manta B et al. The peroxidase and 
peroxynitrite reductase activity of 
human erythrocyte peroxiredoxin 2.  
Archives of Biochemistry and 
Biophysics. 2009;484(2):146-154. DOI: 
10.1016/j.abb.2008.11.017
[6] Diez-Silva M et al. Shape and 
biomechanical characteristics of human 
red blood cells in health and disease. 
MRS Bulletin. 2010;35(5):382-388
[7] Mohandas N. Molecular basis for red 
cell membrane viscoelastic properties. 
Biochemical Society Transactions. 
1992;20(4):776-782. DOI: 10.1042/
bst0200776
[8] An X, Mohandas N. Disorders of 
red cell membrane. British Journal of 
Haematology. 2008;141(3):367-375. 
DOI: 10.1111/j.1365-2141.2008.07091.x
[9] Kay MM, Wyant T, Goodman J.  
Autoantibodies to band 3 during aging 
and disease and aging interventions. 
Annals of the New York Academy 
of Sciences. 1994;719:419-447. DOI: 
10.1111/j.1749-6632.1994.tb56847.x
[10] Umbreit J. Methemoglobin-it’s not 
just blue: A concise review. American 
Journal of Hematology. 2007;82(2):134-
144. DOI: 10.1002/ajh.20738
[11] Pandey KB, Rizvi SI. Biomarkers 
of oxidative stress in red blood cells. 
Biomedical Papers. 2011;155(2):131-136. 
DOI: 10.5507/bp.2011.027
[12] Çimen MYB. Free radical 
metabolism in human erythrocytes. 
Clinica Chimica Acta. 2008;390(1-2):1-
11. DOI: 10.1016/j.cca.2007.12.025
[13] Lu SC. Regulation of glutathione 
synthesis. Molecular Aspects of 
Medicine. 2009;30(1-2):42-59. DOI: 
10.1016/j.mam.2008.05.005
[14] Griffith OW. Biologic and 
pharmacologic regulation of 
mammalian glutathione synthesis. 
Free Radical Biology & Medicine. 
1999;27(9-10):922-935. DOI: 10.1016/
S0891-5849(99)00176-8
[15] Wu G et al. Glutathione metabolism 
and its implications for health. The 
Journal of Nutrition. 2004;134(3):489-
492. DOI: 10.1093/jn/134.3.489
[16] Raftos JE, Whillier S, Kuchel 
PW. Glutathione synthesis and turnover 
in the human erythrocyte: Alignment 
of a model based on detailed enzyme 
kinetics with experimental data. 
The Journal of Biological Chemistry. 
2010;285(31):23557-23567. DOI: 
10.1074/jbc.M109.067017
[17] Pace BS et al. Effects of 
N-acetylcysteine on dense cell formation 
in sickle cell disease. American Journal 
of Hematology. 2003;73(1):26-32. DOI: 
10.1002/ajh.10321
[18] Fitzpatrick AM, Jones DP, Brown 
LAS. Glutathione redox control of 
asthma: From molecular mechanisms to 
therapeutic opportunities. Antioxidants 
15
Interplay between Erythrocyte Peroxidases and Membrane
DOI: http://dx.doi.org/10.5772/intechopen.83590
& Redox Signaling. 2012;17(2):375-408. 
DOI: 10.1089/ars.2011.4198
[19] Lobo V et al. Free radicals, 
antioxidants and functional 
foods: Impact on human health. 
Pharmacognosy Reviews. 
2010;4(8):118-126. DOI: 
10.4103/0973-7847.70902
[20] Valko M et al. Free radicals and 
antioxidants in normal physiological 
functions and human disease. The 
International Journal of Biochemistry 
& Cell Biology. 2007;39(1):44-84. DOI: 
10.1016/j.biocel.2006.07.001
[21] Fridovich I. Oxygen: How do 
we stand it? Medical Principles and 
Practice. 2013;22(2):131-137. DOI: 
10.1159/000339212
[22] Turrens JF. Mitochondrial formation 
of reactive oxygen species. The Journal 
of Physiology. 2003;552(Pt 2):335-344. 
DOI: 10.1113/jphysiol.2003.049478
[23] Mohanty JG, Nagababu E, Rifkind 
JM. Red blood cell oxidative stress 
impairs oxygen delivery and induces red 
blood cell aging. Frontiers in Physiology. 
2014;5:84. 1-6. DOI: 10.3389/
fphys.2014.00084
[24] Maurya PK, Kumar P, Chandra 
P. Biomarkers of oxidative stress in 
erythrocytes as a function of human 
age. World Journal of Methodology. 
2015;5(4):216-222. DOI: 10.5662/wjm.
v5.i4.216
[25] Arashiki N et al. Membrane 
peroxidation and methemoglobin 
formation are both necessary for band 
3 clustering: Mechanistic insights 
into human erythrocyte senescence. 
Biochemistry. 2013;52(34):5760-5769. 
DOI: 10.1021/bi400405p
[26] Rocha S et al. Presence of cytosolic 
peroxiredoxin 2 in the erythrocyte 
membrane of patients with hereditary 
spherocytosis. Blood Cells, Molecules & 
Diseases. 2008;41(1):5-9. DOI: 10.1016/j.
bcmd.2008.02.008
[27] Mannu F et al. Role of hemichrome 
binding to erythrocyte membrane in the 
generation of band-3 alterations in beta-
thalassemia intermedia erythrocytes. 
Blood. 1995;86(5):2014-2020
[28] Waugh SM et al. Heinz bodies 
induce clustering of band 3, 
glycophorin, and ankyrin in sickle cell 
erythrocytes. The Journal of Clinical 
Investigation. 1986;78(5):1155-1160. 
DOI: 10.1172/JCI112696
[29] Pantaleo A et al. Oxidized and 
poorly glycosylated band 3 is selectively 
phosphorylated by Syk kinase to form 
large membrane clusters in normal and 
G6PD-deficient red blood cells. The 
Biochemical Journal. 2009;418(2):359-
367. DOI: 10.1042/BJ20081557
[30] Kanias T, Acker JP. Biopreservation 
of red blood cells--the struggle with 
hemoglobin oxidation. The FEBS 
Journal. 2010;277(2):343-356. DOI: 
10.1111/j.1742-4658.2009.07472.x
[31] Rocha S et al. Linkage of cytosolic 
peroxiredoxin 2 to erythrocyte membrane 
imposed by hydrogen peroxide-induced 
oxidative stress. Blood Cells, Molecules 
& Diseases. 2009;43(1):68-73. DOI: 
10.1016/j.bcmd.2009.03.002
[32] Rocha S et al. Peroxiredoxin 2, 
glutathione peroxidase, and catalase 
in the cytosol and membrane of 
erythrocytes under H2O2-induced 
oxidative stress. Free Radical 
Research. 2015;49(8):990-1003. DOI: 
10.3109/10715762.2015.1028402
[33] Low PS et al. The role of 
hemoglobin denaturation and band 
3 clustering in red blood cell aging. 
Science. 1985;227(4686):531-533. DOI: 
10.1126/science.2578228
[34] Costa E et al. Altered erythrocyte 
membrane protein composition in 
16
Erythrocyte
chronic kidney disease stage 5 patients 
under haemodialysis and recombinant 
human erythropoietin therapy. Blood 
Purification. 2008;26(3):267-273. DOI: 
10.1159/000126922
[35] Costa E et al. Changes in red blood 
cells membrane protein composition 
during hemodialysis procedure. Renal 
Failure. 2008;30(10):971-975. DOI: 
10.1080/08860220802422036
[36] Torres-Ramos YD et al. RBC 
membrane damage and decreased band 
3 phospho-tyrosine phosphatase activity 
are markers of COPD progression. 
Frontiers in Bioscience (Elite Edition). 
2010;2:1385-1393
[37] Kanner J, Harel S. Initiation 
of membranal lipid peroxidation 
by activated metmyoglobin and 
methemoglobin. Archives of 
Biochemistry and Biophysics. 
1985;237(2):314-321. DOI: 
10.1016/0003-9861(85)90282-6
[38] Pandey KB, Rizvi SI. Markers 
of oxidative stress in erythrocytes 
and plasma during aging in humans. 
Oxidative Medicine and Cellular 
Longevity. 2010;3(1):2-12. DOI: 10.4161/
oxim.3.1.10476
[39] Altuntas I et al. Erythrocyte 
superoxide dismutase and 
glutathione peroxidase activities, 
and malondialdehyde and reduced 
glutathione levels in schizophrenic 
patients. Clinical Chemistry 
and Laboratory Medicine. 
2000;38(12):1277-1281. DOI: 10.1515/
CCLM.2000.201
[40] Lovell MA et al. Elevated 
thiobarbituric acid-reactive substances 
and antioxidant enzyme activity in the 
brain in Alzheimer’s disease. Neurology. 
1995;45(8):1594-1601. DOI: 10.1212/
WNL.45.8.1594
[41] Leitinger N. The role of 
phospholipid oxidation products 
in inflammatory and autoimmune 
diseases: Evidence from animal 
models and in humans. Subcellular 
Biochemistry. 2008;49:325-350. DOI: 
10.1007/978-1-4020-8830-8_12
[42] Lee S et al. Role of phospholipid  
oxidation products in atherosclerosis. 
Circulation Research. 2012;111(6): 
778-799. DOI: 10.1161/CIRCRESAHA. 
111.256859
[43] Durak İ et al. Oxidant/antioxidant 
status of erythrocytes from patients 
with chronic renal failure: Effects of 
hemodialysis. Medical Principles and 
Practice. 2001;10(4):187-190. DOI: 
10.1159/000050367
[44] Mondola P et al. The Cu, Zn 
superoxide dismutase: Not only 
a dismutase enzyme. Frontiers in 
Physiology. 2016;7:594. 1-8. DOI: 
10.3389/fphys.2016.00594
[45] Nicholls P, Peter C. Enzymology 
and structure of catalases. Advances in 
Inorganic Chemistry. 2000;51:51-106. 
DOI: 10.1016/S0898-8838(00)51001-0
[46] Wood ZA et al. Structure, 
mechanism and regulation of 
peroxiredoxins. Trends in Biochemical 
Sciences. 2003;28(1):32-40. DOI: 
10.1016/S0968-0004(02)00003-8
[47] Brigelius-Flohe R, Maiorino 
M. Glutathione peroxidases. Biochimica 
et Biophysica Acta. 2013;1830(5):3289-
3303. DOI: 10.1016/j.bbagen.2012.11.020
[48] Berg JM, Tymoczko JL, Stryer L.  
Biochemistry. 5th ed. USA: W.H.  
Freeman; 2002
[49] Yasemin BM, Hamdi O, Nazmi 
O. The mechanism of inhibition 
of human erythrocyte catalase by 
azide. Turkish Journal of Biology. 
2004;28:65-70
[50] Switala J, Loewen PC. Diversity of 
properties among catalases. Archives 
17
Interplay between Erythrocyte Peroxidases and Membrane
DOI: http://dx.doi.org/10.5772/intechopen.83590
of Biochemistry and Biophysics. 
2002;401(2):145-154. DOI: 10.1007/
s00018-003-3206-5
[51] Reid TJ et al. Structure and heme 
environment of beef liver catalase 
at 2.5 A resolution. Proceedings of 
the National Academy of Sciences 
of the United States of America. 
1981;78(8):4767-4771. DOI: 10.1073/
pnas.78.8.4767
[52] Chelikani P, Fita I, Loewen 
PC. Diversity of structures and 
properties among catalases. Cellular 
and Molecular Life Sciences. 
2004;61(2):192-208. DOI: 10.1007/
s00018-003-3206-5
[53] Kodydkova J et al. Human catalase, 
its polymorphisms, regulation and 
changes of its activity in different 
diseases. Folia Biologica (Praha). 
2014;60(4):153-167
[54] Vainshtein BK et al. Three-
dimensional structure of the 
enzyme catalase. Nature. 
1981;293(5831):411-412
[55] Kirkman HN et al. Mechanisms 
of protection of catalase by 
NADPH. Kinetics and stoichiometry. 
The Journal of Biological Chemistry. 
1999;274(20):13908-13914. DOI: 
10.1074/jbc.274.20.13908
[56] Kirkman HN, Galiano S, Gaetani 
GF. The function of catalase-bound 
NADPH. The Journal of Biological 
Chemistry. 1987;262(2):660-666
[57] Kirkman HN, Gaetani 
GF. Catalase: A tetrameric enzyme 
with four tightly bound molecules of 
NADPH. Proceedings of the National 
Academy of Sciences of the United 
States of America. 1984;81(14):4343-
4347. DOI: 10.1073/pnas.81.14.4343
[58] Chance B. An intermediate 
compound in the catalase-hydrogen 
peroxide reaction. Acta Chemica 
Scandinavica. 1947;1:236-267. DOI: 
10.3891/acta.chem.scand.01-0236
[59] Johnson RM et al. The effects of 
disruption of genes for peroxiredoxin-2, 
glutathione peroxidase-1, and catalase 
on erythrocyte oxidative metabolism. 
Free Radical Biology & Medicine. 
2010;48(4):519-525. DOI: 10.1016/j.
freeradbiomed.2009.11.021
[60] Cho CS et al. Irreversible 
inactivation of glutathione peroxidase 
1 and reversible inactivation of 
peroxiredoxin II by H2O2 in red blood 
cells. Antioxidants & Redox Signaling. 
2010;12(11):1235-1246. DOI: 10.1089/
ars.2009.2701
[61] Abou-Seif MA, Youssef 
AA. Evaluation of some biochemical 
changes in diabetic patients. Clinica 
Chimica Acta. 2004;346(2):161-170. 
DOI: 10.1016/j.cccn.2004.03.030
[62] Casado A et al. Superoxide 
dismutase and catalase blood levels 
in patients with malignant diseases. 
Cancer Letters. 1995;93(2):187-192. 
DOI: 10.1016/0304-3835(95)03808-A
[63] Sousa RT et al. Oxidative stress in 
early stage bipolar disorder and the 
association with response to lithium. 
Journal of Psychiatric Research. 
2014;50:36-41. DOI: 10.1016/j.
jpsychires.2013.11.011
[64] Flohé L, Gunzler WA, Schock 
HH. Glutathione peroxidase: A 
selenoenzyme. FEBS Letters. 
1973;32(1):132-134. DOI: 
10.1016/0014-5793(73)80755-0
[65] Epp O, Ladenstein R, Wendel 
A. The refined structure of the 
selenoenzyme glutathione peroxidase at 
0.2-nm resolution. European Journal of 
Biochemistry. 1983;133(1):51-69. DOI: 
10.1111/j.1432-1033.1983.tb07429.x
[66] Lubos E, Loscalzo J, Handy 
DE. Glutathione peroxidase-1 in 
18
Erythrocyte
health and disease: From molecular 
mechanisms to therapeutic 
opportunities. Antioxidants & Redox 
Signaling. 2011;15(7):1957-1997. DOI: 
10.1089/ars.2010.3586
[67] Zimmermann R et al. Inhibition 
of lipid peroxidation in isolated inner 
membrane of rat liver mitochondria 
by superoxide dismutase. FEBS 
Letters. 1973;29(2):117-120. DOI: 
10.1016/0014-5793(73)80539-3
[68] Gaetani GF et al. Predominant role 
of catalase in the disposal of hydrogen 
peroxide within human erythrocytes. 
Blood. 1996;87(4):1595-1599
[69] Cohen G, Hochstein P. Glutathione 
peroxidase: The primary agent for 
the elimination of hydrogen peroxide 
in erythrocytes. Biochemistry. 
1963;2(6):1420-1428. DOI: 10.1021/
bi00906a038
[70] Johnson RM et al. Hemoglobin 
autoxidation and regulation of 
endogenous H2O2 levels in erythrocytes. 
Free Radical Biology & Medicine. 
2005;39(11):1407-1417. DOI: 10.1016/j.
freeradbiomed.2005.07.002
[71] Flohé L et al. Glutathione 
peroxidase, V. The kinetic mechanism. 
Hoppe-Seyler’s Zeitschrift 
für Physiologische Chemie. 
1972;353(6):987-999
[72] Lee TH et al. Peroxiredoxin II 
is essential for sustaining life span 
of erythrocytes in mice. Blood. 
2003;101(12):5033-5038. DOI: 10.1182/
blood-2002-08-2548
[73] Low FM et al. Peroxiredoxin 
2 functions as a noncatalytic 
scavenger of low-level hydrogen 
peroxide in the erythrocyte. Blood. 
2007;109(6):2611-2617. DOI: 10.1182/
blood-2006-09-048728
[74] Nagababu E et al. Role of 
peroxiredoxin-2 in protecting RBCs 
from hydrogen peroxide-induced 
oxidative stress. Free Radical 
Research. 2013;47(3):164-171. DOI: 
10.3109/10715762.2012.756138
[75] Peskin AV et al. The high reactivity 
of peroxiredoxin 2 with H2O2 is not 
reflected in its reaction with other 
oxidants and thiol reagents. The 
Journal of Biological Chemistry. 
2007;282(16):11885-11892. DOI: 
10.1074/jbc.M700339200
[76] Ho YS et al. Mice lacking catalase 
develop normally but show differential 
sensitivity to oxidant tissue injury. 
The Journal of Biological Chemistry. 
2004;279(31):32804-32812. DOI: 
10.1074/jbc.M404800200
[77] Ogasawara Y et al. Structural 
and functional analysis of native 
peroxiredoxin 2 in human red blood 
cells. The International Journal 
of Biochemistry & Cell Biology. 
2012;44(7):1072-1077. DOI: 10.1016/j.
biocel.2012.04.008
[78] Jang HH et al. Two enzymes in 
one. Cell. 2004;117(5):625-635. DOI: 
10.1016/j.cell.2004.05.002
[79] Han Y et al. Peroxiredoxin II is 
essential for preventing hemolytic 
anemia from oxidative stress through 
maintaining hemoglobin stability. 
Biochemical and Biophysical 
Research Communications. 
2012;426(3):427-432. DOI: 10.1016/j.
bbrc.2012.08.113
[80] Melo D, Ribeiro S, Santos-Silva 
A, Rocha S. Role of peroxiredoxin 
2 in erythrocyte antioxidant defense: 
Peroxidase and chaperone. Free 
Radical Biological and Medicine. 
2018;120(Suppl):S83. DOI: 10.1016/j.
freeradbiomed.2018.04.274
[81] Moore RB et al. Reconstitution 
of Ca(2+)-dependent K+ transport 
in erythrocyte membrane vesicles 
requires a cytoplasmic protein. The 
19
Interplay between Erythrocyte Peroxidases and Membrane
DOI: http://dx.doi.org/10.5772/intechopen.83590
Journal of Biological Chemistry. 
1991;266(28):18964-18968
[82] Brizuela M et al. Treatment 
of erythrocytes with the 2-cys 
peroxiredoxin inhibitor, Conoidin A, 
prevents the growth of Plasmodium 
falciparum and enhances parasite 
sensitivity to chloroquine. PLoS One. 
2014;9(4):e92411. 1-8. DOI: 10.1371/
journal.pone.0092411
[83] Memon A et al. Identification 
of differentially expressed proteins 
during human urinary bladder cancer 
progression. Cancer Detection and 
Prevention. 2005;29(3):249-255. DOI: 
10.1016/j.cdp.2005.01.002
[84] Noh DY et al. Overexpression 
of peroxiredoxin in human breast 
cancer. Anticancer Research. 
2001;21(3B):2085-2090
[85] Yoshida Y et al. 
Hydroxyoctadecadienoic acid and 
oxidatively modified peroxiredoxins 
in the blood of Alzheimer’s disease 
patients and their potential as 
biomarkers. Neurobiology of Aging. 
2009;30(2):174-185. DOI: 10.1016/j.
neurobiolaging.2007.06.012
[86] Kwon HS et al. Hyperoxidized 
peroxiredoxins in peripheral blood 
mononuclear cells of asthma patients 
is associated with asthma severity. Life 
Sciences. 2012;90(13-14):502-508. DOI: 
10.1016/j.lfs.2012.01.003
[87] Ogasawara Y et al. A simple high 
performance liquid chromatography 
method for quantitatively 
determining the reduced form 
of peroxiredoxin 2 and the mass 
spectrometric analysis of its oxidative 
status. Journal of Chromatography 
B. 2015;997:136-141. DOI: 10.1016/j.
jchromb.201506.007
[88] Mueller S, Riedel HD, Stremmel 
W. Direct evidence for catalase as 
the predominant H2O2 -removing 
enzyme in human erythrocytes. Blood. 
1997;90(12):4973-4978
[89] Gaetani GF et al. Catalase and 
glutathione peroxidase are equally 
active in detoxification of hydrogen 
peroxide in human erythrocytes. Blood. 
1989;73(1):334-339
[90] Johnson RM et al. Oxidation of 
glutathione peroxidase-deficient red 
cells by organic peroxides. Blood. 
2002;100(4):1515-1516. DOI: 10.1182/
blood-2002-04-1124
[91] Haruyama T et al. Negatively 
charged lipids are essential for 
functional and structural switch of 
human 2-Cys peroxiredoxin II. Journal 
of Molecular Biology. 2018;430(5):602-
610. DOI: 10.1016/j.jmb.2017.12.020
[92] Matte A et al. Peroxiredoxin-2: A 
novel regulator of iron homeostasis in 
ineffective erythropoiesis. Antioxidants 
& Redox Signaling. 2018;28(1):1-14. 
DOI: 10.1089/ars.2017.7051
[93] Rinalducci S et al. Peroxiredoxin-2 
as a candidate biomarker to test 
oxidative stress levels of stored red 
blood cells under blood bank conditions. 
Transfusion. 2011;51(7):1439-1449. 
DOI: 10.1111/j.1537-2995.2010.03032.x
[94] van Gestel RA et al. Quantitative 
erythrocyte membrane proteome 
analysis with blue-native/SDS 
PAGE. Journal of Proteomics. 
2010;73(3):456-465. DOI: 10.1016/j.
jprot.2009.08.010
[95] Allen DW et al. Increased 
membrane binding of erythrocyte 
catalase in hereditary spherocytosis and 
in metabolically stressed normal cells. 
Blood. 1977;49(1):113-123
[96] Bayer SB et al. Interactions between 
peroxiredoxin 2, hemichrome and the 
erythrocyte membrane. Free Radical 
Research. 2016;50(12):1329-1339. DOI: 
10.1080/10715762.2016.1241995
20
Erythrocyte
[97] D'Alessandro A et al. Time-
course investigation of SAGM-stored 
leukocyte-filtered red bood cell 
concentrates: From metabolism 
to proteomics. Haematologica. 
2012;97(1):107-115. DOI: 10.3324/
haematol.2011.051789
[98] Matte A et al. Membrane association 
of peroxiredoxin-2 in red cells is 
mediated by the N-terminal cytoplasmic 
domain of band 3. Free Radical Biology 
& Medicine. 2013;55:27-35. DOI: 
10.1016/j.freeradbiomed.2012.10.543
[99] Matte A et al. Peroxiredoxin-2 
expression is increased in beta-
thalassemic mouse red cells but 
is displaced from the membrane 
as a marker of oxidative stress. 
Free Radical Biology & Medicine. 
2010;49(3):457-466. DOI: 10.1016/j.
freeradbiomed.2010.05.003
